LAWRENCE, Mass., July 13, 2015 /PRNewswire/ -- NxStage Medical,
Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis
products, today announced plans to release its financial results
for the second quarter ended June 30,
2015, on Thursday, August 6,
2015, before the opening of the financial markets.
NxStage will also host a conference call at 9:00 a.m. Eastern Time on Thursday, August 6, 2015 to discuss its second
quarter financial results. To listen to the conference call, please
dial 877-392-9886 (domestic) or 707-287-9329 (international). The
call will also be webcast LIVE and can be accessed via the investor
relations section of the Company's website at
http://ir.nxstage.com.
A replay of the conference call will be available two hours
after the completion of the call through August 14, 2015. To access the replay, dial
855-859-2056 (domestic) or 404-537-3406 (international) and
reference conference ID 77465339. An online archive of the
conference call can be accessed via the investor relations section
of the Company's website at http://ir.nxstage.com.
About NxStage
NxStage Medical, Inc. (Nasdaq: NXTM) is
a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops,
manufactures and markets innovative products for the treatment of
end-stage renal disease (ESRD) and acute kidney failure. For more
information on NxStage and its products, please visit the Company's
website at www.nxstage.com.
Forward-Looking Statements
This Release contains
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. All statements
contained in this Release that are not clearly historical in nature
are forward-looking, and the words "anticipate", "believe",
"expect", "estimate", "plan" and similar expressions are generally
intended to identify forward- looking statements. The
forward-looking statements in this Release include NxStage's plan
to release its financial results on August
6, 2015. Actual results may differ materially from those
indicated by these forward-looking statements as a result of
various important factors including, but not limited to, unexpected
difficulty in closing the Company's financial books for the quarter
and other factors that are discussed in NxStage's Quarterly Report
on Form 10-Q for the quarter ended June 30,
2015 filed with the SEC. NxStage is under no obligation to
(and expressly disclaims any such obligation to) update or alter
its forward-looking statements, whether as a result of new
information, future events or otherwise.
Contact: Kristen K. Sheppard,
Esq.
VP, Investor Relations
ksheppard@nxstage.com
Photo -
http://photos.prnewswire.com/prnh/20110503/MM94799LOGO
Photo - http://photos.prnewswire.com/prnh/20150624/225341
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nxstage-to-report-second-quarter-2015-financial-results-300112381.html
SOURCE NxStage Medical, Inc.